Immunomodulatory effects of quinolones

The Lancet Infectious Diseases
A Dalhoff, Itamar Shalit

Abstract

We review data on the in-vitro, ex-vivo, in-vivo, and clinical effects of fluoroquinolones on the synthesis of cytokines and their mechanisms of immunomodulation. In general, most fluoroquinolone derivatives superinduce in-vitro interleukin 2 synthesis but inhibit synthesis of interleukin 1 and tumour necrosis factor (TNF)alpha; furthermore, they enhance significantly the synthesis of colony-stimulating factors (CSF). Fluoroquinolones affect in-vivo cellular and humoral immunity by attenuating cytokine responses. Interleukins 10 and 12 have an important role in the functional differentiation of immunocompetent cells and trigger the initiation of the acquired immune response. In addition, certain fluoroquinolones were seen to enhance haematopoiesis by increasing the concentrations of CSF in the lung as well as in the bone marrow and shaft. Those fluoroquinolones exerting significant effects on haematopoiesis were those with a cyclopropyl moiety at position N1 of their quinolone core structure. Mechanisms that could explain the various immunomodulatory effects of fluoroquinolones include: (1) an effect on intracellular cyclic adenosine-3',5'-monophosphate and phosphodiesterases; (2) an effect on transcription factors such as nucl...Continue Reading

References

Jun 1, 1992·The Journal of Antimicrobial Chemotherapy·S GollapudiH Thadepalli
Jun 1, 1992·The Journal of Antimicrobial Chemotherapy·H ThadepalliS Gollapudi
Jan 1, 1990·International Journal of Immunopharmacology·S BaillyM A Gougerot-Pocidalo
Dec 1, 1991·Clinical and Experimental Immunology·K G StünkelH J Zeiler
Feb 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·P M Tulkens
Apr 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·I Shalit
Jun 1, 1990·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·K Riesbeck, A Forsgren
Oct 1, 1990·The Journal of Antimicrobial Chemotherapy·M B CarlierP M Tulkens
Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·K RiesbeckA Forsgren
Jul 1, 1989·Reviews of Infectious Diseases·A ForsgrenK Riesbeck
Jan 1, 1989·Antimicrobial Agents and Chemotherapy·F PallaviciniP Nervo
Feb 1, 1986·Antimicrobial Agents and Chemotherapy·S V GollapudiH Thadepalli
May 1, 1988·The Journal of Antimicrobial Chemotherapy·Y RocheM A Gougerot-Pocidalo
Apr 1, 1987·Immunopharmacology·Y RocheM A Gougerot-Pocidalo
Jun 1, 1987·The Journal of Antimicrobial Chemotherapy·Y RocheJ J Pocidalo
May 1, 1987·Antimicrobial Agents and Chemotherapy·A ForsgrenT F Tedder
May 1, 1987·Antimicrobial Agents and Chemotherapy·A ForsgrenT F Tedder
Nov 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·N A Buchmeier, R D Schreiber
Oct 1, 1983·European Journal of Clinical Microbiology·D Milatovic
Nov 1, 1984·Antimicrobial Agents and Chemotherapy·M A GonzalezB Painter
Oct 1, 1994·Dental Clinics of North America·G T Terézhalmy, M A Pyle
Oct 1, 1994·The Journal of Antimicrobial Chemotherapy·A M CuffiniN A Carlone
Mar 1, 1994·Immunopharmacology·K Riesbeck, A Forsgren
Jun 7, 1994·Proceedings of the National Academy of Sciences of the United States of America·E StanleyA R Dunn
Apr 1, 1993·Antimicrobial Agents and Chemotherapy·S J Froelich-AmmonN Osheroff
Apr 1, 1993·Antimicrobial Agents and Chemotherapy·T Yoshida, S Mitsuhashi
Apr 16, 1998·Immunology Today·G A Rook, J L Stanford
Jun 13, 1998·The Journal of Pharmacy and Pharmacology·P J Kramer
Oct 21, 1998·Infectious Disease Clinics of North America·D E Nix
Jun 18, 1999·Gastroenterology Clinics of North America·R B Stein, S B Hanauer

❮ Previous
Next ❯

Citations

Jan 27, 2007·Inflammatory Bowel Diseases·Guy LahatIna Fabian
Aug 19, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M PaulL Leibovici
Jun 23, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S PadronesJ Dorca
Mar 2, 2005·International Journal of Antimicrobial Agents·Magdalena LeivaMaria Jimenez-Valera
May 9, 2008·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Tomoyuki WadaYuichi Ohashi
Jan 13, 2010·Health Physics·G David Ledney, Thomas B Elliott
Apr 27, 2007·Southern Medical Journal·Mesut Ogrendik
Jan 17, 2008·Respirology : Official Journal of the Asian Pacific Society of Respirology·Heng-Ching HuangYin-Ching Chuang
Oct 18, 2006·Antimicrobial Agents and Chemotherapy·Koh TakeyamaYoshio Kuroki
Jul 9, 2010·Clinical Microbiology Reviews·Soichiro Kanoh, Bruce K Rubin
Oct 26, 2012·Interdisciplinary Perspectives on Infectious Diseases·Axel Dalhoff
Nov 19, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kwanghee KimWilliam H McBride
Oct 1, 2009·Respiratory Research·Gregor S ZimmermannJuergen Behr
Feb 14, 2006·Critical Care : the Official Journal of the Critical Care Forum·Grant W Waterer, Jordi Rello
Sep 10, 2013·PloS One·Claudia MancaSelvakumar Subbian
Apr 7, 2010·International Journal of Chronic Obstructive Pulmonary Disease·Marc MiravitllesUNKNOWN EVOCA Study Group
May 14, 2010·Clinical Ophthalmology·Timothy L ComstockJin-Zhong Zhang
Oct 25, 2012·Emerging Infectious Diseases·Etienne RiviereMaïté Longy-Boursier
Apr 19, 2013·American Journal of Respiratory and Critical Care Medicine·Zahoor AhmadEric L Nuermberger
Mar 3, 2004·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Takeshi FujiiAikichi Iwamoto
May 24, 2014·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Gabriel J SeifertUwe A Wittel
Jul 22, 2008·Nature Biotechnology·Ge ShanPeng Jin
Nov 25, 2014·Expert Review of Respiratory Medicine·Chris StockmannCatherine M T Sherwin
Jun 24, 2008·Expert Opinion on Pharmacotherapy·Marc Miravitlles, Antonio Anzueto

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.